CKD - Chronic Kidney Disease study: Letter Intervention
Official title The Use of Risk Prediction to Identify Patients at Risk for Chronic Kidney Disease: Patient and Provider Interventions for Patients at High Risk for Chronic Kidney Disease
ClinicalTrials.gov ID: NCT07857200
What this study is testing
- What it's testing
- The study wants to see whether sending structured messages to doctors and patients leads to more people completing kidney lab tests (blood eGFR and urine albumin).
- Who it's for
- Adults who have been identified as having a high risk of chronic kidney disease.
- What's involved
- Each patient’s primary care doctor gets a notice about the risk. Half of the patients receive a mailed letter and a quarter receive a phone call, encouraging them to have the recommended kidney tests done during routine care.
- Time commitment
- No extra clinic visits are required; participants only receive the communication and complete the usual lab tests as advised.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- At high risk for CKD as determined by CKD model developed in Phase 1
- Age 18-80 as of date of data pull
- At least 12 months of health plan coverage
- Speaks English or Spanish
- We will include both paneled and unpaneled patients
You likely can't join if
- On the research exclusion list between 1/1/2013 and date of the data pull
- On hospice, or have conditions that indicate end of life (metastatic cancer, on dialysis, etc.)
- Non-English / non-Spanish speaking (those who are excluded from the intervention arm solely due to language barriers will be reported to the IRB at...
- Pregnant patients.
- Patients who have a completed both the eGFR and uACR within the 12 months prior to the date of cohort identification.
The study team makes the final eligibility decision.
Where it is enrolling
- Portland, Oregon, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Portland, Oregon, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.